MIER1
Mesoderm induction early response protein 1
Also known as: hMI-ER1, KIAA1610, MI-ER1, MIER1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N108
- Gene
- MIER1
- Ensembl
- ENSG00000198160
- Chromosome
- 1
- Canonical length
- 512 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a protein that was first identified in Xenopus laevis by its role in a mesoderm induction early response (MIER). The encoded protein functions as a transcriptional regulator. Alternatively spliced transcript variants encode multiple isoforms, some of which lack a C-terminal nuclear localization signal. [provided by RefSeq, May 2013]
Canonical amino-acid sequenceUniProt
512 residues, UniProt reviewed canonical sequence.
>Q8N108|MIER1
1 MAEPSVESSS PGGSATSDDH EFDPSADMLV HDFDDERTLE EEEMMEGETN FSSEIEDLAR
61 EGDMPIHELL SLYGYGSTVR LPEEDEEEEE EEEEGEDDED ADNDDNSGCS GENKEENIKD
121 SSGQEDETQS SNDDPSQSVA SQDAQEIIRP RRCKYFDTNS EVEEESEEDE DYIPSEDWKK
181 EIMVGSMFQA EIPVGICRYK ENEKVYENDD QLLWDPEYLP EDKVIIFLKD ASRRTGDEKG
241 VEAIPEGSHI KDNEQALYEL VKCNFDTEEA LRRLRFNVKA AREELSVWTE EECRNFEQGL
301 KAYGKDFHLI QANKVRTRSV GECVAFYYMW KKSERYDFFA QQTRFGKKKY NLHPGVTDYM
361 DRLLDESESA ASSRAPSPPP TASNSSNSQS EKEDGTVSTA NQNGVSSNGP GEILNKEEVK
421 VEGLHINGPT GGNKKPLHAD MDTNGYETDN LTTDPKLAHM TARNENDFDE KSERPAKRRR
481 VNSNGKESPG SSEFFQEAVS HGKFEELENT DDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MIER1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 92 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 92 nTPM
- colon: 26 nTPM
- liver: 23 nTPM
- thymus: 23 nTPM
- rectum: 22 nTPM
- adrenal gland: 20 nTPM
Single-cell type
- neutrophil progenitors: 673 nCPM
- neutrophils: 612 nCPM
- monocyte progenitors: 250 nCPM
- mast cells: 225 nCPM
- t-cells: 178 nCPM
- sertoli cells: 171 nCPM
Immune cell
- basophil: 44 nTPM
- neutrophil: 37 nTPM
- eosinophil: 27 nTPM
- MAIT T-cell: 22 nTPM
- non-classical monocyte: 21 nTPM
- gdT-cell: 19 nTPM
Brain region
- white matter: 34 nTPM
- cerebellum: 30 nTPM
- basal ganglia: 29 nTPM
- medulla oblongata: 29 nTPM
- hypothalamus: 28 nTPM
- thalamus: 27 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.29
- gnomAD missense Z
- 1.54
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromatin remodeling
- negative regulation of transcription by RNA polymerase II
- positive regulation of canonical NF-kappaB signal transduction
- regulation of DNA-templated transcription
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MIER1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MIER1 as an antibody target. Whether an autoantibody or antibody against MIER1 could matter depends on whether native MIER1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MIER1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MIER1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...